In lung cancer, HURP is also significantly up-regulated, and high expression of HURP implies shorter overall survival time and recurrence-free survival time in lung cancer patients, and is a promising biomarker for lung cancer diagnosis and prognosis evaluation [20]. Here, DLGAP5 is linked to lung carcinoma.